Clinical Trials of New Drugs in Practice: Contracts, Budgets and Negotiation

Annotation The lecture will provide practical insight into the system of clinical trials of new medicinal products and Sponsor–CRO–site collaboration. Students will understand the importance of effectively negotiating a Clinical Trial Agreement (CTA) and budget to protect the hospital, principal investigator and study team, and learn why active negotiation can bring the site more than 25% in additional funding. The lecture will also briefly introduce the regulatory framework and the roles of EMA, FDA and SÚKL.
Interested in the programme? Please submit your request via the form. Based on your request, we will arrange the details and agree on a suitable date.
Arrange a date Contact the lecturer

Basic Information

  • Programme type: Lecture with time for discussion or a practical workshop
  • Primary target group: Bachelor's and Master's students and PhD students
  • Also available for: Academic staff, if required
  • Duration: 2–3 teaching hours, as required
  • Capacity: No limit
  • Language: Czech, English
  • Date: By arrangement

Detailed Description

The lecture will introduce the practical operation of clinical trials of new medicinal products, covering the roles of the pharmaceutical company (Sponsor), Contract Research Organisation (CRO) and research site, the phases of clinical research and work with the study protocol, as well as the contractual, financial and regulatory aspects of conducting a clinical trial.

Particular emphasis will be placed on the Clinical Trial Agreement (CTA), its key provisions, payment terms, liability, data protection and the negotiation process between the CRO, sponsor and hospital. Students will also learn about the preparation and negotiation of clinical trial budgets, the principles of TCPP, Fair Market Value and Anti-Bribery and Anti-Corruption, as well as mechanisms for escalating budget requests to the sponsor.

Practical examples will demonstrate how effective contractual and budget negotiations can protect the hospital, principal investigator and study team and can significantly increase the funding available for conducting a clinical trial. The regulatory framework for clinical trials and the roles of EMA, FDA and SÚKL will also be briefly introduced. The lecture will include time for discussion and answering students' questions.

What Participants Will Learn

  • How clinical trials work in practice
  • Who the Sponsor, CRO and site are and how they cooperate
  • What to look out for in a Clinical Trial Agreement (CTA)
  • How a clinical trial budget is prepared and negotiated
  • What can actually be influenced when negotiating with the sponsor
  • How to protect the interests of the hospital, principal investigator and study team
  • What roles EMA, FDA and SÚKL play
  • Practical examples of contractual and budget negotiations

Contacts

Programme Coordinator

Mgr. BcA. Ivo Svejkovský Ph.D., MBA

ivo.svejkovsky@ruk.cuni.cz | +420 771 128 396

Lecturer

Mgr. BcA. Ivo Svejkovský Ph.D., MBA

Director of the Centre for Knowledge and Technology Transfer at Charles University

Contact Person

Mgr. BcA. Ivo Svejkovský Ph.D., MBA

ivo.svejkovsky@ruk.cuni.cz | +420 771 128 396


Last change: August 21, 2026 12:21 
Write us...
Contact

The Centre for Knowledge and Technology Transfer of the Charles University


Office address:

Petrská 1180/3

110 00 Prague 1

Telephone: +420 224 491 255

E-mail:

Contact our team.


Mailing address:

Ovocný trh 560/5

116 36 Prague 1

Czech Republic


IN: 00216208

TIN: CZ 00216208


How to get there